02 Sep Literature review of tumour biomarker tests (2015)
The Department of Health engaged HealthConsult to undertake a literature review of several tumour biomarker tests that are included on the Pathology Services Table of the Medicare Benefits Schedule (MBS). The purpose of the literature review was to assess the clinical relevance of the tumour biomarkers that are included in existing MBS items, and to determine whether any additional biomarkers should be considered for inclusion. The literature review involved a comprehensive literature search and preparation of a summary document outlining the findings from published systematic reviews and recommendations from recent clinical practice guidelines. The project was undertaken to inform discussions at the meeting of the Pathology Services Advisory Committee (PSAC) in February 2015. The project commenced in early February 2015 and was completed by the end of February 2015.